BioSpecifics Technologies Reveals Positive Top-Line Results From Stage 2 Study Of CCH For Treatment of Human Lipoma
June 13, 2016 at 09:49 AM EDT
BioSpecifics Technologies Corp. (NASDAQ: BSTC) revealed Monday positive, statistically significant top-line results from its ...